MedPath
HSA Approval

COMBIDERM CREAM

SIN05109P

COMBIDERM CREAM

COMBIDERM CREAM

October 8, 1990

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07CC01

betamethasone and antibiotics

Manufacturer Information

APOTHECA MARKETING PTE LTD

PT KALBE FARMA TBK

Active Ingredients

GENTAMICIN SULPHATE

0.1%

Gentamicin

CLOTRIMAZOLE

1%

Clotrimazole

BETAMETHASONE DIPROPIONATE

0.05%

Betamethasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COMBIDERM CREAM - HSA Approval | MedPath